Ahmed, S., Kadhim, K. (2024). The Role of Glial Fibrillary Acidic Protein (GFAP) and Epithelial Membrane Antigen (EMA) in the Differentiation and Diagnosis of Glial Tumors. , 23(4), 472-477. doi: 10.52573/ipmj.2024.136783
Summer Osam Ahmed; Khitam Razzaq Kadhim. "The Role of Glial Fibrillary Acidic Protein (GFAP) and Epithelial Membrane Antigen (EMA) in the Differentiation and Diagnosis of Glial Tumors". , 23, 4, 2024, 472-477. doi: 10.52573/ipmj.2024.136783
Ahmed, S., Kadhim, K. (2024). 'The Role of Glial Fibrillary Acidic Protein (GFAP) and Epithelial Membrane Antigen (EMA) in the Differentiation and Diagnosis of Glial Tumors', , 23(4), pp. 472-477. doi: 10.52573/ipmj.2024.136783
Ahmed, S., Kadhim, K. The Role of Glial Fibrillary Acidic Protein (GFAP) and Epithelial Membrane Antigen (EMA) in the Differentiation and Diagnosis of Glial Tumors. , 2024; 23(4): 472-477. doi: 10.52573/ipmj.2024.136783

The Role of Glial Fibrillary Acidic Protein (GFAP) and Epithelial Membrane Antigen (EMA) in the Differentiation and Diagnosis of Glial Tumors

Iraqi Postgraduate Medical Journal
Article 15, Volume 23, Issue 4, October 2024, Pages 472-477    PDF (341.08 K)
Document Type: Research Paper
DOI: 10.52573/ipmj.2024.136783
Authors
Summer Osam Ahmed* 1; Khitam Razzaq Kadhim2
1Al-Amal National Hospital for Cancer management
2Collage of Medicin/ Baghdad University
Abstract
Background: CNS tumors diagnosis represents a challenge in histopathological examination. EMA and GFAP are widely used markers in neurosurgical pathology that help in the diagnosis of many commonly occurring tumors and differentiating them from other mimickers.
Aim of study: To assess the value of EMA and GFAP in the diagnosis of ependymal tumors compared with other glial tumors. Evaluate the pattern of expression of these markers. The value of glial fibrillary acidic protein positivity in the diagnosis of ependymoma and diffuse fibrillary astrocytoma.
Materials and method: The present study is a retrospective study over a period of one year, the paraffin blocks were collected from the archive of the department of pathology, Ghazi Al –Hariri specialized surgical hospital, over the period of 4 years, from March 2015 to October 2019, they included 15 cases of ependymoma and 15 cases of diffuse fibrillary astrocytoma. Total number was 30 cases. The markers used were EMA, and GFAP. The manual method of staining was used in this study.
Result: Both markers showed positivity in studied cases, the finding of 5 EMA dots/ high-power field was associated with a sensitivity of 86% and a specificity of 80%. The presence of ring-like EMA positive structures was less sensitive (33%), but highly specific (100%). GFAP was useful in highlighting the growth pattern of these tumors, and in ependymoma it was mostly expressed in cells and fibrillary processes around vessels (pseudorosettes) and in true rosettes.
Conclusion: Distinct punctate and ring like EMA staining might serve as sensitive and specific markers of ependymal differentiation in glial tumors and, thus, may aid the diagnosis of ependymoma. As for GFAP marker, although it was expressed in both ependymoma and glial tumors, it can provide significant value in highlighting the growth pattern of these tumors, and in excluding other mimickers.
Keywords
GFAP,,; ,،؛EMA,,; ,،؛ependymoma
References
  1. Munshi A, Jalali R. Therapy for glioma: Indian perspective. Indian J Cancer 2009;46:127-31.
  2. World Health Organization Eastern Mediterranean Regional Office. Iraqi Tumor Registry Cancer Data for 2017-2018. Available from: http://www.emro.who.int/irq/iraq-news/cancer-data-for-20172018-announced-in-iraq.html. [Last accessed 2021 Mar 26].
  3. Takei H, Bhattacharjee MB, Rivera A, Dancer Y, Powell SZ. New immunohistochemical markers in the evaluation of central nervous system tumors: A review of 7 selected adult and pediatric brain tumors. Arch Pathol Lab Med 2007;131:234-41.
  4. Inoue, Akihiro, et al. "Usefulness of intraoperative rapid immunohistochemistry in the surgical treatment of brain tumors." Neuropathology3 ,2023:209-20.‏
  5. David NL, Arie P, Guido R, Andreas VD, Dominique FB, Webster KC. The 2016 World Health Organization Classification of Tumors of the Central Nervous System. Acta Neuropathol. 2016; 131: 803-20.
  6. Cizkova, Katerina, et al. "Comparative analysis of immunohistochemical staining intensity determined by light microscopy, ImageJ and QuPath in placental Hofbauer cells." Acta histochemica et cytochemica1 .2021:21-29.‏
  7. Hasselblatt M, Paulus W. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas. Acta neuropathologica. 2003;106:385-88.
  8. Cruz-Sanchez FF, Garcia-Bachs M, Rossi ML, Rodriguez-Prados S, Ferrer I, Coakham HB, Ferreres JC, Figols J, Palacin A Epithelial differentiation in gliomas, meningiomas and choroid plexus papillomas. Virchows Arch [B] .1992; 62:25–34.
  9. Figarella-Branger D, Gambarelli D, Dollo C, Devictor B, Perez-Castillo AM, Genitori L, Lena G, Choux M, Pellissier JF Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and post-operative survival in 16 cases. Acta Neuropathol .1991;82:208-16.
  10. Uematsu Y, Rojas-Corona RR, Llena JF, Hirano A Distribution of epithelial membrane antigen in normal and neoplastic human ependyma. Acta Neuropathol .1989;78:325-28.
  11. Vege KD, Giannini C, Scheithauer BW The immunophenotype of ependymomas. Appl Immunohistochem Mol Morphol .2000; 8:25-31.
  12. Kaneko Y, Takeshita I, Matsushima T, Iwaki T, Tashima T, Fukui M Immunohistochemical study of ependymal neoplasms: histological subtypes and glial and epithelial characteristics. Virchows Arch [A] .1990; 417:97-103.
  13. Cruz-Sanchez FF, Rossi ML, Esiri MM, Reading M Epithelial membrane antigen expression in ependymomas. Neuropathol Appl Neurobiol .1988;14:197-205.
  14. Hitchcock E, Morris CS Cross reactivity of anti-epithelial membrane antigen monoclonal for reactive and neoplastic glial cells. J Neurooncol .1987;4:34-52.
  15. Ho DM, Hsu CY, Wong TT, Ting LT, Chiang H Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol .2000;99:482-88.
  16. Miettinen M Chordoma. Antibodies to epithelial membrane antigen and carcinoembryonic antigen in differential diagnosis. Arch Pathol Lab Med 1984;108:891-92.
  17. Reifenberger G, Weber T, Weber RG, Wolter M, Brandis A, Kuchelmeister K, Pilz P, Reusche E, Lichter P, Wiestler OD Chordoid glioma of the third ventricle: immunohistochemical and molecular genetic characterization of a novel tumor entity. Brain Pathol 1999;9:617-26.
  18. Madabhushi V, Venkata RI, Garikaparthi S, Kakarala SV, Duttaluru SS. Role of immunohistochemistry in diagnosis of brain tumors: A single institutional experience. J NTR Univ Health Sci. 2015;4:103-11.
  19. Brehar FM, Arsene D, Brinduse LA, Gorgan MR. Immunohistochemical analysis of GFAP-δ and nestin in cerebral astrocytomas. Brain tumor pathology. 2015;32:90-98.
 

Statistics
Article View: 277
PDF Download: 107


Journal Management System. Powered by iJournalPro.com